Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-10 Sale | 2025-10-14 8:11 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $53.98 | $1,619,340 | 906,131 (Direct) | View |
| 2025-10-07 Sale | 2025-10-09 6:58 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $46.08 | $576,001 | 216,516 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $47.76 | $596,978 | 301,880 (Indirect Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:39 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 586 | $43.02 | $25,210 | 256,898 (Indirect Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:39 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 659 | $43.02 | $28,350 | 90,829 (Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:38 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 659 | $43.02 | $28,350 | 57,752 (Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:36 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 553 | $43.02 | $23,790 | 166,571 (Direct) | View |
| 2025-09-10 Sale | 2025-09-12 8:36 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 31,796 | $43.23 | $1,374,665 | 883,919 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 7:48 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $44.17 | $552,137 | 229,958 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 7:47 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $46.08 | $576,035 | 314,966 (Indirect Direct) | View |
| 2025-08-12 Sale | 2025-08-13 6:37 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $47.79 | $597,326 | 327,466 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 6:37 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $48.59 | $1,457,596 | 490,757 (Direct) | View |
| 2025-08-12 Sale | 2025-08-12 8:32 pm | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 3,000 | $47.46 | $142,371 | 21,195 (Direct) | View |
| 2025-08-05 Sale | 2025-08-07 09:00 am | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $49.3 | $616,299 | 174,557 (Direct) | View |
| 2025-07-16 Sale | 2025-07-18 6:00 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $52.95 | $529,467 | 222,693 (Direct) | View |
| 2025-07-10 Sale | 2025-07-11 6:30 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $51.16 | $1,534,895 | 520,757 (Direct) | View |
| 2025-07-07 Sale | 2025-07-09 7:00 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $51.09 | $638,661 | 187,057 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 6:00 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $52.88 | $105,760 | 29,891 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:09 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 6,620 | $54.84 | $363,041 | 549,867 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:08 pm | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 848 | $54.84 | $46,504 | 23,452 (Direct) | View |
| 2025-06-20 Sale | 2025-06-20 9:08 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 875 | $54.59 | $47,766 | 31,698 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:07 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,129 | $54.84 | $61,914 | 166,234 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:07 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 1,634 | $54.84 | $89,609 | 57,521 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:07 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 1,633 | $54.84 | $89,554 | 90,598 (Direct) | View |
| 2025-06-18 Sale | 2025-06-20 9:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 1,453 | $54.84 | $79,683 | 256,594 (Indirect Direct) | View |
| 2025-06-16 Sale | 2025-06-20 09:22 am | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $54.23 | $542,306 | 92,231 (Direct) | View |
| 2025-06-16 Sale | 2025-06-20 09:22 am | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $54.14 | $108,272 | 96,755 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:34 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 37,837 | $54.05 | $2,044,940 | 556,487 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:33 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 2,358 | $54 | $127,323 | 167,363 (Direct) | View |
| 2025-06-10 Sale | 2025-06-12 6:33 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 2,804 | $53.99 | $151,402 | 59,155 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-10 Exercise | 2025-10-14 8:11 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $19.87 | 906,131 (Direct) | View |
| 2025-10-10 Exercise | 2025-10-14 8:11 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $0 | 906,131 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 26,000 | $23.02 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 23,832 | $19.97 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 15,000 | $8.13 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 90,832 | $0 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $25.2 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $26.32 | 1,293,000 (Direct) | View |
| 2025-10-07 Exercise | 2025-10-09 6:58 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $28.35 | 216,516 (Direct) | View |
| 2025-10-07 Exercise | 2025-10-09 6:58 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 216,516 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-09 6:58 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 52,212 | $0.615 | 526,114 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-09 6:58 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 52,212 | $0 | 526,114 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:30 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 301,880 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $21.1 | 301,880 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 8:36 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,919 | $19.87 | 883,919 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 8:36 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 13,022 | $6.364 | 883,919 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 8:36 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 14,941 | $0 | 883,919 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 295 | $28.35 | 229,958 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 5,161 | $6.364 | 229,958 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 229,958 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 7,044 | $21.09 | 229,958 (Direct) | View |
| 2025-09-02 Exercise | 2025-09-04 7:47 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 314,966 (Direct) | View |
| 2025-09-02 Exercise | 2025-09-04 7:47 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $21.1 | 314,966 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 9:32 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 2,600 | $19.62 | 44,135 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 9:32 pm | N/A 2034-04-28 | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 2,600 | $0 | 44,135 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-13 6:37 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 327,466 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-13 6:37 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $21.1 | 327,466 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-12 8:32 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 3,000 | $7.009 | 21,195 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-12 8:32 pm | N/A 2029-04-02 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 3,000 | $0 | 21,195 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 09:00 am | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 174,557 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 09:00 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $21.09 | 174,557 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $19.87 | 222,693 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 6:00 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $0 | 222,693 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 7:00 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 187,057 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 7:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $21.09 | 187,057 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 890 | $23.87 | 91,488 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 890 | $23.87 | 257,484 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 193 | $23.87 | 31,891 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 890 | $23.87 | 58,411 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 890 | $23.87 | 167,124 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 299 | $23.87 | 23,751 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 890 | $23.87 | 550,757 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $0 | 92,231 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $21.1 | 92,231 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $19.87 | 96,755 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-20 09:22 am | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 2,000 | $0 | 96,755 (Direct) | View |